KALA BIO, Inc.
KALA
$0.57
$0.011.92%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 72.92% | 44.87% | 29.94% | 8.01% | 3.85% |
| Total Depreciation and Amortization | -31.84% | -4.60% | 22.39% | 27.69% | -3.26% |
| Total Amortization of Deferred Charges | -33.96% | -47.62% | -- | -137.59% | -121.47% |
| Total Other Non-Cash Items | -132.75% | -109.04% | -98.19% | -29.08% | 182.34% |
| Change in Net Operating Assets | -1,421.44% | -141.88% | -210.34% | 37.73% | -82.62% |
| Cash from Operations | 23.25% | 4.75% | -8.88% | 1.38% | 15.72% |
| Capital Expenditure | 100.63% | 100.51% | 100.48% | 53.42% | 52.82% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -43,650.00% | -- | -- | -- | -100.16% |
| Cash from Investing | -3,899.43% | -3,497.44% | 92.79% | 42.47% | -101.81% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -162.36% | -343.07% | -346.09% | -42,205.56% | -- |
| Issuance of Common Stock | -21.32% | -65.51% | -65.47% | -24.52% | -25.09% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -78.92% | -100.00% | -100.00% |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 100.00% | 100.00% | -0.84% | -0.84% | -0.84% |
| Cash from Financing | -227.62% | -134.65% | -138.89% | -84.43% | -85.37% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -42.50% | -546.71% | -15,353.15% | -309.65% | -550.41% |